Since the analysis of clinical specimens revealed an inverse correlation between SOX17 and NRF2, we suggested that the downregulated transcription activity of SOX17 in ESCC may cause dysregulation of cytoprotective enzymes controlled by NRF2, resulting in CCRT resistance. Here, SOX17 is linked to esophageal squamous cell carcinoma.